What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Pulmonary embolism
Menno V. Huisman mostly deals with Pulmonary embolism, Internal medicine, Surgery, Thrombosis and Deep vein.
His Pulmonary embolism study combines topics in areas such as Respiratory disease, Prospective cohort study, Venous thrombosis and Radiology.
His work investigates the relationship between Internal medicine and topics such as Cardiology that intersect with problems in Platelet aggregation inhibitor.
His work carried out in the field of Surgery brings together such families of science as Platelet, Aspirin, Epidemiology and Risk factor.
His study looks at the relationship between Thrombosis and topics such as Cumulative incidence, which overlap with Hazard ratio, Arterial embolism, Central venous catheter and Catheter related thrombosis.
Menno V. Huisman has included themes like Anesthesia, Clinical trial, Embolism, Anticoagulant and Complication in his Deep vein study.
His most cited work include:
- Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report (2635 citations)
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19. (1976 citations)
- 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism (1754 citations)
What are the main themes of his work throughout his whole career to date?
Pulmonary embolism, Internal medicine, Radiology, Surgery and Thrombosis are his primary areas of study.
In the field of Pulmonary embolism, his study on Pulmonary angiography overlaps with subjects such as In patient.
His work in Internal medicine tackles topics such as Cardiology which are related to areas like Diabetes mellitus.
His work on Venous thrombosis and Venography as part of general Surgery research is frequently linked to Geneva score, thereby connecting diverse disciplines of science.
His study focuses on the intersection of Thrombosis and fields such as Anticoagulant with connections in the field of Rivaroxaban.
His study in Intensive care medicine is interdisciplinary in nature, drawing from both Venous thromboembolism and Clinical trial.
He most often published in these fields:
- Pulmonary embolism (48.66%)
- Internal medicine (46.94%)
- Radiology (22.49%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (46.94%)
- Pulmonary embolism (48.66%)
- Atrial fibrillation (10.76%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Pulmonary embolism, Atrial fibrillation, Thrombosis and In patient.
His studies examine the connections between Internal medicine and genetics, as well as such issues in Cardiology, with regards to Anticoagulant therapy.
His Pulmonary embolism research includes elements of Radiology, Pulmonary hypertension, Emergency medicine and Intensive care medicine.
His Radiology research focuses on Venous thrombosis and how it relates to Magnetic resonance imaging and Cancer.
His Atrial fibrillation research is multidisciplinary, relying on both Medical prescription, Clinical trial and Antithrombotic.
His Thrombosis research includes themes of Thrombus and Pneumonia.
Between 2018 and 2021, his most popular works were:
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19. (1976 citations)
- Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. (636 citations)
- 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) : The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) (214 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Disease
His primary areas of investigation include Internal medicine, Pulmonary embolism, Incidence, Thrombosis and Confidence interval.
Much of his study explores Internal medicine relationship to Cardiology.
He combines subjects such as Cancer, Pulmonary hypertension and Emergency medicine with his study of Pulmonary embolism.
His studies deal with areas such as Adverse effect and Randomized controlled trial as well as Incidence.
His research integrates issues of Thrombus, Coagulopathy and Pneumonia in his study of Thrombosis.
The study incorporates disciplines such as Odds ratio and Pulmonary artery in addition to Confidence interval.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
